AASLD 2017
The Liver Meeting 2017, organised by the American Association for the Study of Liver Diseases (AASLD), took place in Washington DC, USA, from 20 to 24 October 2017.
-
20-24 October 2017
-
Washington DC, US
More work and lower drug prices are needed to eliminate hepatitis C worldwide
Sofosbuvir/ledipasvir for 8 weeks cures acute HCV in people with HIV
Curing hepatitis C with DAAs linked to 71% reduction in liver cancer
Daily aspirin therapy linked to lower liver cancer risk
Hepatitis C testing linked to reduced opioid use among people who inject drugs
Maviret cures most people with HCV genotype 3 and those with cirrhosis
HCV infection is rising among HIV-positive gay men in San Diego
Hepatitis C cure leads to improved quality of life